Lupin launches generic Ancobon

David Salazar

1/8/2018

Lupin has added to its generics lineup with its version of Valeant Pharmaceuticals’ Ancobon (flucytosine) capsules. The drug is indicated to treat serious infections caused by candida and/or Cryptococcus.

The product will be available from Lupin in 250- and 500-mg dosage strengths. These dosage strengths had U.S. sales of roughly $48 million for the 12 months ended October 2017, according to IQVIA data.

Sycamore Partners reportedly working on financing to acquire Walgreens

A potential buyout reportedly would include terms loans, a bridge loan and asset-based lending.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

Walgreens reportedly close to roughly $10B deal to go private

The deal could be finalized by Thursday, per a WSJ report.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.